BOARD OF DIRECTORS
Microbix’s board members have extensive experience that is relevant and helpful to the company. Their qualifications include accounting and finance, contracts and law, life sciences and medical care, as well as corporate governance.
The board takes an active role in developing vision and strategy, advising management on key matters and providing oversight on policies and reporting.
Mr. Groome is the President and CEO of Microbix. Before joining Microbix, he was CEO of a company listed on the TSX Venture Exchange and EVP of a TSX-listed company – both in life sciences. Prior to his operational roles, he headed the healthcare activities of two national investment dealers. He has more than 25 years of experience as a leader, executive, equity analyst, investment banker, and corporate advisor. He has also been a member of the Life Sciences Advisory Group of Global Affairs Canada, and a director of public and private companies.
Mr. Renner, CEO and partner in Zydus Pharmaceuticals, Pennington N.J., has over 25 years experience in the pharmaceutical industry. He has had a successful career leading businesses with many drug approvals in the US.
Mark A. Cochran, Ph.D.
Dr. Cochran has been serving on the board since 1988. His professional experience spans all levels of the drug discovery and development value chain including operational and executive roles in venture capital, pharmaceutical and biotechnology industries. His previous experience includes Bayer Pharmaceuticals, last serving as Vice President of Business Development, Biotechnology, in Berkeley, California. He is currently Managing Director, Johns Hopkins HealthCare Solutions, an operating division of Johns Hopkins Medicine/ HealthCare.
CHAIRMAN OF THE BOARD
Mr. Marino has over 30 years of experience in corporate legal roles and executive management functions, with particular emphasis in transaction based activities related to domestic and international corporate development. He also has considerable experience in conflict resolution and litigation management.
Dr. Peter M. Blecher
Dr. Peter M. Blecher worked as an Emergency Room physician for close to 25 years. He is a Medical Director of NeuPath Centres for Pain & Spine, and is a credentialed pain practitioner with both the American and Canadian Academies of Pain Medicine. Dr. Blecher is a co-founder and Chief Medical Officer of both Entourage Health, a federally licensed medical cannabis producer, and FH Health, a health-tech leader reimagining diagnostic and wellness services through technology and design principles.
Vaughn C. Embro-Pantalony
Mr. Embro-Pantalony has served as a Director of the Company since 2007. He has held several executive positions in life sciences with responsibility for licensing, business development, and strategic planning, including VP Finance & CFO of Novopharm Limited; VP, Information Technology & CIO of Bayer Inc., VP, Finance & Administration of Bayer Healthcare; and General Manager, Nitrogen Products for Terra International (Canada) Ltd. He is a Chartered Director (C. Dir.) and Audit Committee Certified (A.C.C.) through the Directors College, McMaster University.
Ms. Stewart is founder, President, and CEO of Syntax Strategic, a leading firm in the sector of advocacy and communication for the public and private sectors in Canada. She is a renowned expert in this field, and is actively involved with media, business, and the community.